Literature DB >> 28386459

Pathogenesis of Warthin's tumors.

Yevhen V Kuzenko1, Anatoly M Romanuk1, Olena Olegivna Dyachenko1, Olena Hudymenko1.   

Abstract

INTRODUCTION: Warthin's tumor, also known as papillary cystadenoma lymphomatosum, monomorphic adenoma, or adenolymphoma, is a benign cystic tumor of the salivary glands containing abundant lymphocytes and lymph node-like stroma. It is named after the pathologist Aldred Scott Warthin, who described two cases in 1929.
OBJECTIVE: The aim of this study is to analyze the pathogenesis of Warthin's tumor.
METHODS: A total of 15 patients with Warthin's tumor were studied. Hematoxylin and eosin stains, which have been used for at least a century and are still essential for recognizing various tissue types and the morphologic changes for cancer diagnosis, were used. Warthin's tumor was evaluated for the expression of MGMT, CD3, HSP90AA1, MMP-1, Bcl-2, CD79A, IgG, Ki-67, p53, IgM, OPN, S100, myeloperoxidase, and VEGF by immunohistochemistry.
RESULTS: Immunohistochemical staining confirmed that the immune cells within the follicles of Warthin's tumor were positive for MGMT (10.0 ± 0.34%), Ki-67 (13.3 ± 0.45%), Bcl-2 (42.6 ± 8.33), and p53 (11.6 ± 2.3). The immune cells associated with CD3 were present at the stroma of residual cells (47.3 ± 3.89); however, they were not present in the epithelium cell layers. B cells (CD79A) consistent with germinal centers were present within the immune cells and formed follicles (43.2 ± 13.5%).
CONCLUSIONS: Histopathological analysis of the stroma and parenchyma revealed balanced distribution of epithelial and stromal component. Epithelial component of the Warthin's tumor is the trigger for the tumor process. This study indicates that the Warthin tumor is a consequence of inflammatory etiology.

Entities:  

Keywords:  Warthin’s tumor; adenoma; cystic papillary adenoma; lymphoma; salivary gland

Year:  2016        PMID: 28386459      PMCID: PMC5370350          DOI: 10.1556/1646.8.2016.2.2

Source DB:  PubMed          Journal:  Interv Med Appl Sci        ISSN: 2061-1617


  46 in total

1.  Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro.

Authors:  A Elgavish; C Prince; P L Chang; K Lloyd; R Lindsey; R Reed
Journal:  Prostate       Date:  1998-05       Impact factor: 4.104

2.  p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.

Authors:  Maria P Foschini; Alessia Gaiba; Roberto Cocchi; Maria G Pennesi; Annalisa Pession
Journal:  Int J Surg Pathol       Date:  2005-10       Impact factor: 1.271

3.  Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease.

Authors:  N Lügering; R Stoll; T Kucharzik; K W Schmid; G Rohlmann; G Burmeister; C Sorg; W Domschke
Journal:  Digestion       Date:  1995       Impact factor: 3.216

4.  Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.

Authors:  A B Tuck; D M Arsenault; F P O'Malley; C Hota; M C Ling; S M Wilson; A F Chambers
Journal:  Oncogene       Date:  1999-07-22       Impact factor: 9.867

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin.

Authors:  D R Senger; C A Perruzzi
Journal:  Biochim Biophys Acta       Date:  1996-11-08

7.  Receptor-ligand interaction between CD44 and osteopontin (Eta-1).

Authors:  G F Weber; S Ashkar; M J Glimcher; H Cantor
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

8.  S100A12 (EN-RAGE) in monitoring Kawasaki disease.

Authors:  Dirk Foell; Fukiko Ichida; Thomas Vogl; Xianyi Yu; Rui Chen; Toshio Miyawaki; Clemens Sorg; Johannes Roth
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

9.  bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.

Authors:  J Diebold; G Baretton; M Felchner; W Meier; K Dopfer; M Schmidt; U Löhrs
Journal:  Am J Clin Pathol       Date:  1996-03       Impact factor: 2.493

10.  Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.

Authors:  Alexandra Corina Faur; Elena Lazar; Marioara Cornianu
Journal:  APMIS       Date:  2013-08-13       Impact factor: 3.205

View more
  10 in total

1.  Classical Hodgkin lymphoma arising from heterotopic Warthin's tumor in the cervical lymph node: A case report.

Authors:  Li Jun; Zhu Ming
Journal:  Oncol Lett       Date:  2018-05-09       Impact factor: 2.967

2.  The role of fine-needle aspiration biopsy (FNAB) in Warthin tumour diagnosis and management.

Authors:  Alzbeta Jechova; Martin Kuchar; Stepan Novak; Vladimir Koucky; Lucie Dostalova; Michal Zabrodsky; David Kalfert; Jan Plzak
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-18       Impact factor: 2.503

3.  Simultaneous Expression of PD-1 and PD-L1 in Peripheral and Central Immune Cells and Tumor Cells in the Benign and Malignant Salivary Gland Tumors Microenvironment.

Authors:  Mohammad Reza Haghshenas; Nasrollah Erfani; Sajjad Gerdabi; Fatemeh Asadian; Razie Kiani; Bijan Khademi
Journal:  Head Neck Pathol       Date:  2022-09-28

4.  Malignant transformation of Warthin's tumor into squamous cell carcinoma: A case report.

Authors:  Leyi Shou; Xiaodan Chen; Junjie Yang; Yiqian Jiang
Journal:  Oncol Lett       Date:  2022-05-12       Impact factor: 3.111

5.  Ultrasound-guided ethanol sclerotherapy for multifocal unilateral Warthin's tumor after partial parotidectomy.

Authors:  Esther Lee; Christopher Badger; Ishwarya S Mamidi; Daniel A Benito; Lilun Li; Joseph F Goodman; Punam G Thakkar; Arjun Joshi
Journal:  Ultrasound       Date:  2021-07-21

6.  Novel interleukin-33 and its soluble ST2 receptor as potential serum biomarkers in parotid gland tumors.

Authors:  Pawel Sowa; Maciej Misiolek; Maciej Zielinski; Bogdan Mazur; Monika Adamczyk-Sowa
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

7.  Cytomorphological findings in diagnosis of Warthin tumor

Authors:  Fatma Fulya Köybaşioğlu; Binnur Önal; Ünsal Han; Ayşegül Adabağ; Ahmet Şahpaz
Journal:  Turk J Med Sci       Date:  2020-02-13       Impact factor: 0.973

8.  Aberrant Expression of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) in Warthin Tumors.

Authors:  Robert Mandic; Abbas Agaimy; Daniel Pinto-Quintero; Katrin Roth; Afshin Teymoortash; Hans Schwarzbach; Christine G Stoehr; Fiona R Rodepeter; Boris A Stuck; Michael Bette
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

9.  Low Molecular Weight Cytokeratin Immunohistochemistry Reveals That Most Salivary Gland Warthin Tumors and Lymphadenomas Arise in Intraparotid Lymph Nodes.

Authors:  Anne C McLean-Holden; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2020-08-31

10.  Multifocal Warthin's Tumor: An Uncommon Presentation of Bilateral Cervical Lymphadenopathy.

Authors:  Ryan A Rimmer; Elizabeth E Cottrill
Journal:  Case Rep Otolaryngol       Date:  2018-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.